I believe the efficacy results are already done and have been released by the company. We had up to a 70% improvement in biomarkers for psoriasis including inflammatory markers. These are excellent results. The IRB safety trials are either complete or about to be completed by the end of this month IMO. I'm hoping the company will compile their results and publish them. The bio-data from the trials are now protected via a USPTO patent application allowing the company to approach manufacturers for the production of our psoriasis cream. It is now "market ready" according to OWCP. Hoping to hear about distribution into the German markets any day now.